Strategy and mechanism of One Health governance: case study of China
Science in One Health · 2025 · 4 · 100098
DOI: 10.1016/j.soh.2024.100098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science in One Health, 2025. Verfasst von Xinchen Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Technologies Research and Development Program, Shanghai Municipal Health Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Strategy and mechanism are crucial components of One Health governance in China, designed to address the interconnected health issues between humans, animals, and the environment. This study aims to evaluate China's current One Health governance framework, identify key strengths and gaps, and provide recommendations for establishing a more integrated and effective system.
Methods
A qualitative approach was employed, including in-depth interviews, policy analysis, and a review of existing literature, to evaluate the strengths and gaps in China's One Health framework.
Results
The analysis identified progress and challenges in six key areas: (1) political commitment: strong national support exists, but lacks a unified strategy; (2) legislation and regulation: notable legislative efforts are in place, yet they remain fragmented; (3) leadership building: effective leadership structures have been established during crises but are not institutionalized; (4) strategic planning: initial regional planning is underway, but a comprehensive national focus is needed; (5) coordination and communication: mechanisms exist but require formalized, consistent information-sharing channels; (6) stakeholder engagement: public and academic awareness is growing, yet local community involvement needs strengthening.
Conclusion
To advance its One Health governance, China must focus on creating a unified strategy, enhancing interdepartmental coordination, and deepening stakeholder engagement, ensuring its alignment with international standards and improving public health outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
- Institute of One Health, Shanghai Jiao Tong University, Shanghai 200025, China.
- School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- National Institute of Parasitic Diseases at Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre…
Förderung
- Key Technologies Research and Development Program
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- Chinese Center for Disease Control and Prevention
- Chinese Academy of Sciences
- National Key Research and Development Program of China
- Duke Kunshan University
Zitieren
APA
Li, X., Zhang, Y., Zhang, Q., Liu, J., Zhu, Z., Feng, X., Han, L., & Zhang, X. (2025). Strategy and mechanism of One Health governance: case study of China. Science in One Health, 4, 100098. https://doi.org/10.1016/j.soh.2024.100098
Vancouver
Li X, Zhang Y, Zhang Q, Liu J, Zhu Z, Feng X, et al. Strategy and mechanism of One Health governance: case study of China. Science in One Health. 2025;4:100098. doi:10.1016/j.soh.2024.100098
BibTeX
@article{Li2025,
author = {Li, Xinchen and Zhang, Yanyan and Zhang, Qiyu and Liu, Jingshu and Zhu, Zelin and Feng, Xinyu and Han, Lefei and Zhang, Xiaoxi},
title = {Strategy and mechanism of One Health governance: case study of China},
journal = {Science in One Health},
year = {2025},
volume = {4},
pages = {100098},
doi = {10.1016/j.soh.2024.100098}
}
EUVIMED